שווי הפעילות העסקית: 180 Life Sciences Corp (ATNF)

ETHZilla Corporation (ATNF) is transforming its operations by building crypto-infrastructure through partnerships with gambling services and blockchain systems. Simultaneously, the company is implementing an innovative therapy against fibrosis by blocking the TNF protein. This chart captures the Enterprise Value at 54.97. Growth prospects are supported by a transition to a virtual drug design model and the optimization of clinical trial logistics.

The stability of ETHZilla Corporation (ATNF) currently depends on the value of its intellectual property in the field of TNF inhibitors. This metric aggregates market capitalization and net debt, reflecting the actual cost of acquiring the business while accounting for all liabilities and liquid assets. By analyzing the company's total buyout price, an investor can assess the effectiveness of the current corporate pivot and the risks of a prolonged technological lull.